enzalutamide
Showing 26 - 50 of 394
Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Prostatic Neoplasms
- MK-5684
- +6 more
- (no location specified)
Nov 21, 2023
Prostatic Tumors, Castration-Resistant Trial in New York (TVB-2640, Enzalutamide)
Not yet recruiting
- Prostatic Neoplasms, Castration-Resistant
- TVB-2640
- Enzalutamide
-
New York, New YorkWeill Cornell Medicine/NewYork-Presbyterian Hospital
Feb 23, 2023
COVID-19 Infection Trial in Bellinzona (Enzalutamide)
Terminated
- COVID-19 Infection
- Enzalutamide
-
Bellinzona, SwitzerlandOncology Institute of Southern Switzerland (IOSI)
Aug 7, 2022
Prostate Cancer Trial in Utrecht (PSMA-PET/CT response evaluation)
Not yet recruiting
- Prostate Cancer
- PSMA-PET/CT response evaluation
-
Utrecht, NetherlandsRoderick van den Bergh
Sep 10, 2022
Cancer of the Prostate, Prostate Cancer Trial in Switzerland (Enzalutamide, Metformin)
Active, not recruiting
- Cancer of the Prostate
- Prostate Cancer
- Enzalutamide
- Metformin
-
Aarau, Switzerland
- +15 more
Jun 9, 2022
Determining Clinical Relevance of Interaction Between
Recruiting
- Drug-drug Interaction
- Blood sampling - Pharmacokinetic assessment
-
Nijmegen, Netherlands
- +2 more
Oct 26, 2022
Castration-Resistant Prostate Carcinoma, Hormone-Resistant Prostate Cancer, PSA Progression Trial in Portland (drug, other,
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- Enzalutamide
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Sep 26, 2022
Metastatic Cancer, Tumor, Prostate Trial in Bronx (Abiraterone acetate, Apalutamide, Enzalutamide)
Not yet recruiting
- Metastatic Cancer
- Neoplasm, Prostate
- Abiraterone acetate
- +2 more
-
Bronx, New YorkJames J. Peters VA Medical Center
Jun 16, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +6 more
- Enzalutamide
-
San Francisco, California
- +1 more
Sep 20, 2022
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco (FOR46, Enzalutamide, Pegfilgrastim)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- Prostate Cancer
- FOR46
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 1, 2022
Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer Trial in Baltimore, Boston, Seattle (Enzalutamide,
Completed
- Prostate Adenocarcinoma
- +2 more
- Enzalutamide
- +3 more
-
Baltimore, Maryland
- +3 more
Mar 30, 2022
Prostatic Tumors, Castration-Resistant Trial in Leiden (Patient-specific adaptive therapy, Abiraterone acetate, Enzalutamide)
Recruiting
- Prostatic Neoplasms, Castration-Resistant
- Patient-specific adaptive therapy
- +2 more
-
Camperdown, New South Wales, Australia
- +6 more
Jan 11, 2023
Prostate Cancer Trial in Washington, Chicago, Baltimore (Enzalutamide, LY2157299)
Recruiting
- Prostate Cancer
- Enzalutamide
- LY2157299
-
Washington, District of Columbia
- +3 more
Jun 1, 2022
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Scottsdale, Jacksonville, Rochester
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- Stage IVB Prostate Cancer AJCC v8
- Biopsy
- +7 more
-
Scottsdale, Arizona
- +2 more
Feb 15, 2023
Prostate Cancer Trial in Japan (Enzalutamide)
Completed
- Prostate Cancer
- Enzalutamide
-
Kita-gun, Kagawa-prefecture, Japan
- +3 more
May 24, 2022
Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore
Recruiting
- Prostate Cancer
- +2 more
- Testosterone Undecanoate
- Enzalutamide
-
Baltimore, MarylandJohns Hopkins Hospital
May 6, 2022
Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston
Recruiting
- Advanced Breast Carcinoma
- +17 more
- Alpelisib
- Enzalutamide
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
COVID-19, Corona Virus Infection Trial in Sweden (Enzalutamide Pill)
Terminated
- COVID-19
- Corona Virus Infection
- Enzalutamide Pill
-
Malmö, Skåne, Sweden
- +5 more
May 30, 2022
Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 18-FDG PET/CT, Whole body MRI)
Completed
- Prostate Cancer Metastatic
- Enzalutamide
- +3 more
-
Leiden, NetherlandsLeiden University Medical Center
Apr 6, 2022
Prostate Cancer Trial in Québec (Enzalutamide capsule)
Recruiting
- Prostate Cancer
- Enzalutamide capsule
-
Québec, CanadaCHU de Québec-Université Laval
Mar 29, 2022
Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Enzalutamide,
Active, not recruiting
- Metastatic Prostate Carcinoma
- +2 more
- Enzalutamide
- Niclosamide
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Feb 23, 2022
Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 11C or 18F-Choline PET/CT, Whole body MRI)
Completed
- Prostate Cancer Metastatic
- Enzalutamide
- +3 more
-
Leiden, NetherlandsLeiden University Medical Center
Apr 6, 2022
Prostate Cancer Trial in Chisinau (enzalutamide, enzalutamide Placebo, digoxin)
Completed
- Prostate Cancer
- enzalutamide
- +3 more
-
Chisinau, Moldova, Republic ofSite MD37301
Jan 14, 2022